RIGEL PHARMACEUTICALS INC — Director's Dealing 2018

Mar 23, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RIGEL PHARMACEUTICALS INC (RIGL)
CIK: 0001034842
Period of Report: 2018-03-21

Reporting Person: Markel Stacy (EVP Human Resources)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-03-21	Employee Stock Option (Right to Buy)	$3.94	A	125000	Acquired	2028-03-21	Common Stock (125000)	Direct

Footnotes

F1: One fourth (1/4th) of the option vests one year from March 19, 2018 and thereafter the balance of the option vests in equal monthly installments over the next thirty-six (36) months.